Related references
Note: Only part of the references are listed.Randomized Comparison of Tenofovir Disoproxil Fumarate vs Emtricitabine and Tenofovir Disoproxil Fumarate in Patients With Lamivudine-Resistant Chronic Hepatitis B
Scott Fung et al.
GASTROENTEROLOGY (2014)
Efficacy of Adefovir-Based Combination Therapy for Patients with Lamivudine- and Entecavir-Resistant Chronic Hepatitis B Virus Infection
Yun Bin Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Tenofovir-associated Fanconi syndrome in patients with chronic hepatitis B monoinfection
David M. Gracey et al.
ANTIVIRAL THERAPY (2013)
Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: An international multicenter cohort study
Jorg Petersen et al.
JOURNAL OF HEPATOLOGY (2012)
Management of treatment failure in chronic hepatitis B
Fabien Zoulim et al.
JOURNAL OF HEPATOLOGY (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B
S. J. Patterson et al.
GUT (2011)
HEPATITIS Treatment failure in chronic hepatitis B
Fabien Zoulim
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Long-Term Efficacy of Tenofovir Monotherapy for Hepatitis B Virus-Monoinfected Patients After Failure of Nucleoside/Nucleotide Analogues
Florian van Boemmel et al.
HEPATOLOGY (2010)
Performance of Version 2.0 of the Cobas AmpliPrep/Cobas TaqMan Real-Time PCR Assay for Hepatitis B Virus DNA Quantification
Stephane Chevaliez et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Chronic Hepatitis B: Update 2009
Anna S. F. Lok et al.
HEPATOLOGY (2009)
Tenofovir-associated renal and bone toxicity
C. L. N. Woodward et al.
HIV MEDICINE (2009)
A short course of add-on adefovir dipivoxil treatment in lamivudine-resistant chronic hepatitis B patients
R. Idilman et al.
JOURNAL OF VIRAL HEPATITIS (2009)
Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure
Stephanie Villet et al.
JOURNAL OF HEPATOLOGY (2008)
Low resistance to adefovir combined with lamivudine: A 3-year study of 145 lamivudine-resistant hepatitis B patients
Pie-Fro Lampertico et al.
GASTROENTEROLOGY (2007)
Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases
Lesley H. Curtis et al.
MEDICAL CARE (2007)
Antiviral drug-resistant HBV: Standardization of nomenclature and assays and recommendations for management
Anna S. Lok et al.
HEPATOLOGY (2007)
Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B
Irene Rapti et al.
HEPATOLOGY (2007)
Evolution of multi-drug resistant hepatitis B virus during sequential therapy
Hyung Joon Yim et al.
HEPATOLOGY (2006)
HBV drug resistance: Mechanisms, detection and interpretation
T Shaw et al.
JOURNAL OF HEPATOLOGY (2006)
Virologic response and resistance to adefovir in patients with chronic hepatitis B
SK Fung et al.
JOURNAL OF HEPATOLOGY (2006)
Outcome of hepatitis B e antigen-negative chronic hepatitis B on long-term nucleos(t)ide analog therapy starting with lamivudine
GV Papatheodoridis et al.
HEPATOLOGY (2005)
Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B
CL Lai et al.
CLINICAL INFECTIOUS DISEASES (2003)
Long-term safety of lamivudine treatment in patients with chronic hepatitis B
ASF Lok et al.
GASTROENTEROLOGY (2003)
Fanconi syndrome and renal failure induced by tenofovir: A first case report
D Verhelst et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapy
MF Yuen et al.
HEPATOLOGY (2001)
Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B
SNS Ahmed et al.
HEPATOLOGY (2000)
Share Paper
